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Abstract 
Objective: To determine acceptability and preliminary effectiveness of Mind-Body Skills 
Groups (MBSGs) as a treatment for depressed adolescents in primary care.  
Methods:  A single arm clinical trial was conducted. A 10-week MBSG program was 
implemented in primary care. Participants completed self-report measures at baseline, post-
intervention, and 3-months following the MBSGs. Measures included the Children’s Depression 
Inventory-2, Suicidal Ideation Questionnaire, Mindful Attention Awareness Scale, Self-Efficacy 
for Depressed Adolescents, rumination subscale of the Children’s Response Style Questionnaire, 
and a short acceptability questionnaire.  
Results: Participants included 43 adolescents. The total depression scores significantly improved 
following the MBSG intervention and continued to improve significantly from post-treatment to 
follow-up. Mindfulness, self-efficacy, rumination, and suicidal ideation all had significant 
improvement following the intervention. Acceptability of the program was strong, and 
attendance was excellent. 
Discussion: Preliminary evidence suggests that MBSGs are an acceptable treatment for primary 
care settings and lead to improved depression symptoms in adolescents.  
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INTRODUCTION 
Depression affects nearly 14% of US adolescents (Hedden et al., n.d.)  and is associated 
with impaired social functioning, (Carrellas, Biederman, & Uchida, 2017) poor academic 
performance, (Fletcher, 2009) and increased comorbid diagnoses such as anxiety disorder, 
substance abuse disorder, and suicidal behavior. (Avenevoli, Swendsen, He, Burstein, & 
Merikangas, 2015) The most common treatment for adolescents with depression includes 
psychiatric medication and cognitive-behavioral therapy (Thapar, Collishaw, Pine, & Thapar, 
2012); however, adherence to psychiatric medications for adolescents is poor (Fontanella, 
Bridge, Marcus, & Campo, 2011) and linking adolescents to needed outpatient care is difficult 
for families facing multiple barriers to engaging in evidence-based depression treatment.   
One approach to increase engagement in outpatient depression treatment is providing 
behavioral health services in primary care settings through collaborative behavioral healthcare. 
(Collins, Hewson, Munger, & Wade, 2010)  Given that the majority of adolescents receive 
treatment for depression by a healthcare provider in their primary care clinic - rather than by an 
outpatient mental health specialist (Anderson, Chen, Perrin, & Van Cleave, 2015; Olfson, 
Blanco, Wang, Laje, & Correll, 2014) - providing behavioral health services in primary care 
settings can eliminate common barriers to service utilization such as additional costs, 
transportation issues, and perceived stigma related to mental health treatment. (Collins et al., 
2010) Moreover, providing behavioral health treatment in primary care allows for improved 
communication between medical and behavioral health staff regarding co-occurring health 
problems and medication management. (Asarnow, Rozenman, Wiblin, & Zeltzer, 2015; Crowley 
& Kirschner, 2015) Integrating behavioral health services like depression screening, 
psychotherapy, and prescription medication is encouraged by professional agencies such as the 
5 
 
American Academy of Pediatrics (A. H. Cheung et al., 2007; Amy H. Cheung, Zuckerbrot, 
Jensen, Laraque, & Stein, 2018), and collaborative care models have shown to be associated with 
improved health outcomes; (Kodish, Richardson, & Schlesinger, 2019) however, research 
indicates that a substantial amount of youth do not utilize treatment services. (O’Connor et al., 
2016) Thus, innovative programming for adolescent depression treatment in primary care is 
needed.   
 One approach encompasses mind-body modalities (MBM) to reduce depression with 
adolescents. Defined as a collection of healthcare practices aimed at bringing control over the 
mind, body, brain and behavior (“National Center for Complementary and Integrative Health. 
Complementary, Alternative, or Integrative Health: What’s in a name?,” 2018), MBM treatments 
teach a variety of mind-body techniques in one bundled approach; therefore, allowing 
individuals to experiment and choose techniques that work best for their individualized needs. 
Common practices of MBMs include techniques of yoga and meditation, as well as mindfulness 
and deep breathing. Mindfulness-based treatments is one element within MBMs that has gained 
popularity in recent years. For example, in a randomized controlled study with outpatient 
adolescents, 8 weeks of a mindfulness-based stress reduction (MBSR) in addition to usual 
treatment had a significant improvement in depression symptoms compared to usual treatment 
alone. (Biegel, Brown, Shapiro, & Schubert, 2009) In another study with adolescent girls at risk 
for diabetes with mild to moderate depression symptoms, those receiving a mindfulness 
intervention, which included breath awareness, body scanning, mindful eating, and mindful 
movement, had a significantly greater decrease in depression symptoms than those receiving 
cognitive behavioral therapy. (Shomaker et al., 2019) Thus, mindfulness interventions for 
adolescents struggling with depression are promising, but less is known about the effects of 
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MBM treatments - as a whole - on adolescents with depression; particularly in healthcare 
settings.   
The Center for Mind-Body Medicine (CMBM) has developed a MBM program called 
Mind-Body Skills Groups (MBSGs). (J. S. Gordon et al., 2000) This program aims to restore 
psychological wellbeing by teaching diverse, evidence-based mind-body techniques that balance 
physiological functioning, stimulate self-awareness and emotional regulation, and enhance 
imagination and intuition. These techniques include a variety of concentrative MBM practices 
such as mindfulness, and active meditations including slow, deep breathing, mindful eating, and 
movement (i.e. shaking and dancing). Other techniques include biofeedback and autogenic 
training, guided imagery, and self-expression through written words and drawings. A key 
element of this program is the social support provided by the groups; social support has a strong 
association with the absence of depression among adolescents and children. (Gariépy, 
Honkaniemi, & Quesnel-Vallée, 2016) The MBSGs have been shown to be successful in treating 
posttraumatic stress symptoms in adolescents in Kosovo and Gaza (J. S. Gordon, Staples, Blyta, 
Bytyqi, & Wilson, 2008; Staples, Abdel Atti, & Gordon, 2011) as well as depression symptoms 
in war-traumatized children and adolescents in Gaza (Staples et al., 2011);  however, less is 
known about this program’s effectiveness and acceptability for treating adolescent depression 
within a primary care setting in the United States.  
The purpose of the current research was to evaluate an open-trial pilot study aimed to: 1) 
establish acceptability of incorporating MBSGs into primary care settings, 2) garner preliminary 
evidence for effectiveness of the intervention in addressing adolescent depression symptoms and, 
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3) investigate the program’s effects on related outcomes such as suicidal ideation, self-efficacy, 
rumination, and mindfulness. 
METHODS 
Clinic Setting  
 Adolescent participants were seen for care at one of 3 participating primary care clinics in 
an urban hospital system in central Indiana. Clinic staff consisted of primary care doctors, 
psychiatric consultants (e.g., psychiatrist or psychiatric nurse practitioner), registered nurses and 
onsite masters level clinicians who provide collaborative behavioral healthcare services.  
Recruitment and Procedures  
Eligible participants were first identified and approached by behavioral health clinicians 
who provided information regarding the study. If a participant and their parent (or guardian) 
expressed interest, a research assistant later contacted the parent by telephone to answer 
questions and schedule a screening appointment. After obtaining parental informed consent and 
adolescent assent, eligibility was assessed, and baseline measures were collected. Eligibility 
criteria required that the adolescent (1) was a primary care patient of the participating hospital 
system, (2) screened positive for depression through a structured diagnostic interview, (Duncan 
et al., 2018) (3) was 13 to 17 years old, (4) spoke English, and (5) was willing to attend the 
MBSGs for 10 weeks. Adolescents were excluded if they (1) had a history of bipolar disorder or 
psychosis, (2) were at an acute and immediate risk for suicide at the time of screening, (3) lacked 
capacity to provide assent, or (4) had previously participated in a MBSG.   
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Recruitment was conducted in waves over the study period, with up to 12 participants 
recruited per group. Once a MBSG ended, a new wave of participants were recruited. The 
MBSGs were held once per week for 10 weeks and sessions lasted 1.5 hours. Group sessions 
took place during after school hours (e.g., 3 or 4 PM) and were delivered in conference rooms at 
the primary care clinics. Group sessions were facilitated by 2 CMBM-trained behavioral health 
clinicians. The behavioral health clinicians were provided with a manual for delivery instructions 
on the intervention and supervised weekly by CMBM clinical faculty to ensure fidelity to the 
model. During the 10-week series, participants were taught a variety of tools and techniques to 
foster self-awareness and emotional regulation (see Table 1). Participants were asked to 
complete surveys after the MBSG was completed and again approximately 3 months later. 
Adolescents were compensated travel costs for attending each MBSG session ($10), completing 
the screen/baseline procedures ($60), and completing the 2 post-intervention visits ($40 each). 
Additionally, participants could earn chances to draw rewards from a “fishbowl” for 
participating in the treatment (attending group meetings and practicing mind-body skills as 
homework). Prizes included $5 gift cards, $10 gift cards, and one $50 gift card. This project was 
approved by Indiana University’s Institutional Review Board and the participating hospital 
system’s research committee.  
Measures  
Participant demographics were collected during the screening appointment (see Table 2), 
and attendance was recorded at each session.  In addition, all measures below were administered 
at baseline, post-intervention, and 3 months later unless otherwise noted.  
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Acceptability  
 Acceptability was assessed at both time points after the intervention using items 
developed by the research team.  Using a 5-point rating scale (1 = Do Not Agree; 5 = Completely 
Agree) participants responded to the following questions: (1) the MBSGs were useful, (2) I had 
to force myself to attend the MBSGs, (3) I apply what I learned in my everyday life, (4) the 
MBSGs were enjoyable, (5) I would recommend the MBSGs to others, (6) I am certain I will 
benefit from the skills I learn in the long run, and (7) my group facilitators were understanding. 
Acceptability was calculated by computing an average score based on each time point (baseline 
alpha=0.90; 3-month alpha=0.85).  
Depression  
The main outcome of depression was assessed with the Children’s Depression Inventory 
(CDI-2) (Kovacs, 2003) which consists of 28 self-report items rated from 0 (no depressive 
symptom) to 2 (significant depressive symptom). The CDI-2 instrument has two primary indices 
that measure symptoms of emotional problems and functional problems, and 4 subscale items (2 
for each index) that measure symptoms of negative mood/physical symptoms, negative self-
esteem, interpersonal problems, and ineffectiveness. Items are summed into raw scores and then 
transformed into T-scores, which are used to determine depression classification.   
Suicidal Ideation  
Suicidal ideation was measured using the Suicidal Ideation Questionnaire (SIQ; grades 
10th -12th) and junior high school version (SIQ-JR; grades 7th - 9th). (Reynolds, William M. 
Mazza, 1988) Both versions of the SIQ assess the frequency in which adolescents cognitively 
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engaged in thoughts of suicide or death in the past month. The SIQ consists of 30 items and the 
SIQ-JR consists of 15 items.  All items are rated on a 7-point Likert scale (0 = I never had this 
thought; 6 = Almost every day). A cutoff score of  ≥ 41 on the SIQ, or  ≥ 31 on the SIQ-JR, 
indicates a person is at acute risk for suicide. Both SIQ measures also contain critical content 
items which can postulate severe risk for suicide (SIQ = 8 critical items; SIQ-JR = 6 critical 
items). If a participant met the cutoff score, and/or scored high (i.e., 5-6) on at least 3 of the 
critical content items, they were considered at acute risk of suicide and received a clinical 
assessment by a behavioral health clinician.  
Mindfulness 
Adolescent mindfulness was measured using the Mindful Attention Awareness Scale – 
Adolescents (MAAS-A), (Brown, West, Loverich, & Biegel, 2011) a 14-item assessment 
designed to measure enhanced attention and awareness of present reality. The MAAS-A uses 6-
point Likert scale where higher scores reflect greater mindfulness.  
Self-Efficacy  
The Self-Efficacy Questionnaire for Depressed Adolescents (SEQ-DA) is a 12-item self-
report measure of effectiveness in coping with depression. (M. S. Gordon, Tonge, & Melvin, 
2012) Adapted specifically for adolescent depression, the SEQ-DA includes items that measure 
effectiveness in coping with mood and irritability, sleeping patterns, eating behaviors, 
concentration, social interactions, negative thoughts, and thoughts of self-harm. The SEQ-DA is 
evaluated on a 5-point Likert scale where higher total scores indicate greater self-efficacy.  
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Rumination 
Rumination was assessed using the Children’s Response Style Questionnaire -
Rumination (CRSQ-R), a self-report 13-item measure that assesses youth response styles to 
depressed mood. (Abela, Aydin, & Auerbach, 2007) Participants are asked to rate on a 4-point 
Likert scale (0 = almost never to 3 = almost always) the extent to which they adopt a certain 
coping strategy when they feel sad. Total scores are computed by summing the overall score of 
the 13 items. Scores can range from 0-39, with higher total scores indicating higher levels of 
rumination.  
Statistical Analysis 
All outcome analyses only included data from participants who attended at least one 
MBSG. Missing data at the question level were imputed with SYSTAT (v.12.02) using the 
Expectation/Maximization (EM) algorithm except for the SIQ and SIQ-JR, which used the 
author recommendations for prorated scoring. (Reynolds, William M. Mazza, 1988) Data 
analysis was performed using SPSS version 26 (IBM, SPSS). To test change over time, the 
MIXED procedure in SPSS was used to run a linear mixed model to account for clustering of the 
participants within each MBSG and repeated measures over time for individuals. Although this 
3-level model accounted for all the possible levels of variance in the design, for the SIQ, SIQ-JR, 
CRSQ-R and the ineffectiveness and negative self-esteem subscales of the CDI-2, there was not 
enough variance at the clustered MGSG level to give a stable estimate for the variance 
parameters. For these outcomes, a marginal model was used to account for the repeated measures 
of individuals over time. An unstructured covariance matrix of the residuals was used in this 
model. Time was the fixed factor in all models. In addition, the following aspects of participants’ 
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status were included as fixed factors as well as their interactions with time: sex, age, ethnicity, 
and MBSG attendance. If any of these fixed factors or their interactions were significant, they 
were included in the final model. Pairwise comparisons of differences between outcomes at each 
time point were performed using a Sidak correction to control for Type I errors. 
 
RESULTS 
Demographics 
Overall, our study delivered 5 independent MBSGs in the participating primary care 
clinics. A total of 49 adolescents were recruited for the study; of those, 2 participants were 
ineligible due to depression screen failure. Of the remaining 47 participants, 4 adolescents’ data 
were excluded because they did not attend any MBSG sessions. The final sample included 43 
adolescents who were primarily female (79%), Hispanic (67%) and in Junior High (58%; see 
Table 2).  
Acceptability of Intervention 
 Acceptability scores were positive throughout the study (post-intervention = 4.24; 3-
month follow-up visit = 4.26). Attendance for the MBSGs was excellent: only 14% (n = 6) of 
participants attended less than half of the sessions and 86% (n = 37) of participants attended 6 or 
more sessions. In total, 25% (n = 11) had perfect attendance (all 10 sessions).  
Depression Primary Outcome 
The estimated marginal mean scores and the overall level of significance of the changes 
over time are shown in Table 3. There was significant improvement over time in the total CDI-2 
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score as well as for functional and emotional problems and their subscales of negative 
mood/physical symptoms, negative self-esteem, ineffectiveness, and interpersonal problems. 
Pairwise analysis showed significant improvement at the post-intervention time point for the 
total CDI-2 score and all of the scales/subscales (Table 3). In addition, for the total CDI-2 score 
and ineffectiveness subscale, the follow-up time point was significantly lower than the post-
intervention time point (total CDI-2: -2.1 [95% CI, -402 to -0.02]; p = .048) (ineffectiveness: -1.1 
[95% CI, -2.1 to -0.01]; p = .048) showing continued improvement at follow-up. For the other 
scales/subscales there was no statistically significant difference between the post intervention 
and follow-up time points indicating that the improvements were maintained at follow-up. While 
the overall improvement was the same for males and females, males had significantly higher 
ineffectiveness score than females throughout the study (1.8 [95% CI, 0.29 to 3.5]; p = .022 
across all points). For emotional problems and its negative self-esteem subscale, scores from 
Hispanic participants were higher than non-Hispanic participants at all time points, indicating 
more severe emotional problems (2.7 [95% CI, 0.29 to 5.3]; p = .030 across all time points) and 
negative self-esteem (2.4 [95% CI, 0.96 to 3.8]; p = .002 across all time points). Depression 
classifications based on T-Scores are shown in Table 4.  
Secondary Outcomes  
In addition to improved depression, there was significant improvement post-intervention 
in secondary outcomes of mindfulness (MAAS-A), self-efficacy (SEQ-DA), rumination (CRSQ-
R) and suicidal ideation (SIQ and SIQ-JR; see Table 3). There was no statistically significant 
difference between the post-intervention and follow-up time points indicating that the 
improvement was maintained at follow-up.  
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DISCUSSION 
 Adolescent depression is frequently identified and diagnosed by primary care providers, 
yet engagement in mental health treatment is very low in primary care (O’Connor et al., 2016) 
and is often limited to antidepressant medication or therapy. (Merikangas et al., 2010) Given that 
the prevalence of adolescent depression is increasingly high, (Mojtabai, Olfson, & Han, 2016; 
Twenge, Joiner, Rogers, & Martin, 2018) innovative treatment models that are effective and 
keep youth engaged are needed in primary care.  Results from our study suggest that MBSGs 
could be feasible for reducing depression in adolescents seeking mental health treatment in 
primary care. In addition, participants reported significant improvements in mindfulness, self-
efficacy, rumination and suicidal ideation following the MBSG. These results were maintained at 
follow-up. Below we discuss the findings of this work and implications for depression treatment 
for adolescents. 
Acceptability of MBSGs in Primary Care  
Acceptability of MBSGs was strong, with the majority of adolescents attending more 
than half of the sessions and <10% not attending any. Only 4 participants did not attend any 
sessions. Previous studies have shown that integrating behavioral health services into primary 
care is feasible and effective for treating depressed youth as compared to providing usual care 
(Kodish et al., 2019; Richardson et al., 2014); however, collaborative care models primarily 
focus on providing traditional forms of treatment (e.g., psychotherapy or psychiatric medication) 
rather than holistic approaches. Thus, the current study extends the current collaborative care 
model by the integration of a holistic treatment approach in a collaborative care setting.  
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Depression Outcomes 
The primary outcome of interest in the current project was symptoms of depression. 
Following the intervention, overall depression scores (as well as subscales) decreased 
significantly. Decreased scores were well maintained at the 3-month follow-up visit, and overall 
depression as well as one subscale showed increased improvement. Given high rates of 
adolescent depression and suicide (Cha et al., 2018), the finding that suicidal ideation also 
improved significantly over time is important. Further research with a control group is needed, 
but the current findings suggest that MBSGs may be an additional intervention to consider for 
adolescents coping with depression. In addition, given higher subscale scores for males 
(ineffectiveness) and for Hispanics (emotional problems and negative self-esteem), future studies 
will need increased variation in gender and ethnicity to study potential differential effectiveness 
for different populations.   However, the success of this intervention for Hispanic youth who 
have increased rates of depression diagnoses and are less likely to receive mental health 
treatment as compared to Non-Hispanic youth (Control & Prevention, 2017; Merikangas et al., 
2011) is encouraging and important.  
Secondary Outcomes  
 In addition to depression and suicidal thoughts, we included other secondary outcomes to 
identify possible mechanisms of change. Although our sample is too small to test mediational 
mechanisms, participants in our study showed significant improvements in mindfulness and self-
efficacy, as well as diminished rumination. Other studies suggest these could be important 
mediators.  For example, enhanced awareness of reality (i.e., mindfulness) (Kearns et al., 2016), 
greater self-efficacy (M. S. Gordon, Tonge, & Melvin, 2011) and decreased rumination 
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(Michalak, Hölz, & Teismann, 2011) have been shown to be predictive of reductions in 
depression relapse. Youth in our study demonstrated significant improvement in their depressive 
symptoms and a decrease in ruminating thoughts and reported enhanced mindfulness and self-
efficacy behaviors. Thus, findings suggest that MBSGs may contribute in a variety of ways to 
decreasing depression in youth and can be effectively integrated into primary care.  
Limitations 
 Our primary study limitation is the lack of a control group.  While promising, the effects 
of the intervention need to be tested in a rigorous design. In addition, participants were primarily 
Hispanic/Latinx (67%), female (79%) and were not representative of all adolescents who seek 
mental health treatment in primary care. Finally, although the intervention was acceptable from 
the participants’ point of view, we did not assess acceptability from clinic providers or at the 
healthcare system level.  This particular organization has invested heavily in training behavioral 
health clinicians to use the MBSGs, but future studies would be needed to ensure feasibility of 
implementation in other settings as well. 
CONCLUSION 
Adolescence is a period in which health behaviors and states of mind, including 
depression, may shape future health outcomes. Depression is often first recognized and treated 
by primary care providers, yet youth engagement in mental health treatment is poor. (Abuse, 
2018; Anderson et al., 2015) Early recognition and intervention in adolescent depression can 
help alleviate health problems in adulthood. (Naicker, Galambos, Zeng, Senthilselvan, & 
Colman, 2013; Rohde, Lewinsohn, Klein, Seeley, & Gau, 2013) It is important, therefore, to 
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provide effective early interventions in a setting that is easily accessible, and in a way that is 
acceptable to youth. MBSGs in primary care fulfill these criteria and appear to be a promising 
treatment option for youth with depression. Future randomized trials will be important to assess 
the value of including this model of depression treatment in primary care settings.  
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HIGHLIGHTS 
• Adolescent depression is a serious and growing concern that can lead to co-morbid 
diagnoses and negative health outcomes. 
• Primary care settings are an ideal home for receiving depression treatment; however, 
treatments services are often limited in this setting.   
• Preliminary data suggests that a new intervention, Mind-Body Skills Groups, could be an 
effective and feasible treatment for depressed adolescents seeking services in primary 
care.  
• Additional research is needed to understand the full effectiveness, feasibility and 
acceptability of Mind-Body Skills Groups as a depression treatment for adolescents in 
primary care.   
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Table 1. Center for Mind-Body Medicine Model and Techniques *  
Each session is structured with: (1) opening meditation (soft belly breathing); (2) check-in; (3) didactic: 
explanation of a mind-body skill technique (one for each session); (4) experiential exercise: experimentation 
using the mind-body skill technique; (5) sharing of personal experience using the mind-body skill technique; 
and (5)closing meditation (soft belling breathing). 
Session I: Overview of Mind-Body Medicine and Opening Drawings  
 Draw yourself – as you see yourself today.  
 Draw yourself – with your biggest problem, challenge or issue. 
 Draw yourself – with your biggest problem, challenge or issue solved. 
Session II: Autogenic Training and Biofeedback  
 Discuss the biological underpinnings of “mind-body medicine” and use biofeedback skin 
thermometers to demonstrate we can control and affect out physiology (stress response).  
Session III: Meditation 
Discuss the three different types of meditation and how they are useful.  Experience an active 
meditation (shaking and dancing or walking meditation). 
Session IV: Guided Imagery 
 Use “safe place” and “wise-guide” guided imagery to invoke relaxation and intuition.  
Session V: Dialogue with a Symptom 
 Acknowledge the power of writing as a tool for accessing the unconscious and solving problems. 
Practice writing as an exercise for self-expression and insight. 
Session VI: Genograms 
 Create genograms to explore family patterns, identify sources of support, and increase our self-
awareness.   
Session VII: Genograms 
 Continue sharing genograms from session VII. 
Session VIII: Relationship with Food and Mindful Eating 
 Introduce the concept of “food as medicine” and experience mindful eating and share its benefits. 
Session IX: Spirituality 
             Practice forgiveness meditation or loving kindness meditation. 
Session X: Closing Drawings and Closing Ritual 
 Draw yourself – as you are now. 
 Draw yourself – as you’d like to be (personally, professionally, emotionally, etc.). 
 Draw – how you are going to get there. What is the road map? 
*All techniques from the model were covered during the 10-week series; however, the order and 
structure of some sessions may have varied depending on time, level of participation, group 
preference.  
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Table 2. Participant Characteristics (N = 43) 
Characteristics Frequency Percent 
Gender   
 Female 34 79.1% 
 Male 9 20.9 % 
Race   
 White or Caucasian 16 37.2% 
 Black or African American 8 18.6% 
 Multiracial  2 4.7% 
 Refused 17 39.5% 
Ethnicity    
 Hispanic or Latinx 29 67.4% 
 Not Hispanic or Latinx 13 30.2% 
 Participant unsure 1 2.3% 
Education Level  
 8th -9th grade 25 58.2% 
 10th – 12th grade 18 41.8% 
Age (M = 15.2; SD = 1.3) 
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Table 3. Effect of the MBSGs over time 
  Mean Scorea (95% Confidence Interval)   
Outcome Measure Baseline (n = 43)b 
Post Treatment 
(n=39)c 
Follow-up 
(n=39)d 
 Pairwise 
comparisons 
over timee 
p valuef 
CDI-2 Total Score 27.5 (23.3-31.8) 17.5 (13.2-21.8) 15.4 (11.2-19.5) T1 > T2, T3; T2 >T3 < .001 
  Emotional Problems 13.7 (11.9- 15.5) 8.3 (6.6-10.0) 7.4 (5.6-9.1) T1 > T2, T3 <.001 
Negative 
Mood/Physical 
Symptoms 
8.9 (7.4-10.5) 5.5 (4.0-7.1) 5.2 (3.7-6.7) T1 > T2, T3 < .001 
Negative Self-
Esteem 4.9 (4.1-5.8) 3.1 (2.2-3.9) 2.4 (1.7-3.1) T1 > T2, T3 < .001 
  Functional Problems 12.8 (11.1-14.4) 8.5 (6.7-10.2) 7.2 (5.5-8.9) T1 > T2, T3 < .001 
Ineffectiveness 9.6 (8.7-10.6) 6.5 (5.4-7.6) 5.4 (4.3-6.5) T1 > T2, T3; T2 > T3 < .001 
Interpersonal 
Problems 3.7 (2.9-4.6) 2.3 (1.4-3.2) 1.9(1.0-2.8) T1 > T2, T3 < .001 
SIQ  49.8 (31.1-68.4) 28.2 (12.2-44.2) 27.2 (14.2-40.2) T1 > T2, T3 .007 
SIQ-JR 32.1 (24.0-40.2) 20.2 (11.9-28.4) 19.3 (10.9-27.6) T1 > T2, T3 .006 
Mindfulness 45.1 (39.3-50.8) 52.2 (46.4-58.1) 57.3 (51.7-63.0) T1 < T2, T3 .001 
Self-Efficacy 33.2 (28.2-38.2) 41.8 (36.8-46.7) 42.8 (37.9-47.7) T1 < T2, T3 < .001 
Rumination 39.4  (37.1-41.6) 30.9 (28.0-33.9) 31.5 (28.7-34.3) T1 > T2, T3 < .001 
 
 
Abbreviations: T1= Baseline, T2= Post Treatment, T3 = Follow-up 
aMean scores are Estimated Marginal Means from the repeated measures linear mixed models. 
b for Mindfulness and Rumination, n = 42, for SIQ n = 18, for SIQ-JR n = 25 
c for Ineffectiveness and Functional Problems and Total CDI-2, n = 38, for SIQ n = 15, for SIQ-JR n = 
24 
d for SIQ n = 16 , for SIQ-JR n = 23 
e p < .001 for all except CID-2 Total and Ineffectiveness T2 >T3, SIQ and SIQ-JR T1>T3, SIQ-JR 
T1>T2, and Mindfulness T1<T2 where p < .05; Mindfulness T1<T3 and SIQ T1>T2 where p < .01;  
fp value is for the overall change across time.  
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Table 4. Depression Classification Changes based on CDI-2 T-Scores 
 
 Baseline Post Treatment Follow-up 
 T-score Mean (SD) 
Depression 
Classificationa 
T-Score 
Mean (SD) 
Depression 
Classification 
T-Score 
Mean (SD) 
Depression 
Classification 
Male 84.7 (6.4) Very Elevated 75.8 (9.8) Very Elevated 69.4 (12.4) Elevated 
Female 73.3 (9.0) Very Elevated 61.9 (11.5) High Average 58.3 (10.3) Average 
 
aDepression classification categories are as follows: Very Elevated (≥ 70), Elevated (65-69), High 
Average (60-64), Average or Lower (≤59). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
